ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
Dow Jones
39.512,84
0,32%
Euro vs US Dollar
1,07735
-0,13%
Bitcoin
61.284,71
0,80%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. SQZ Biotechnologies Company (SQZ)

  7. SQZ Biotechnologies Company (SQZ) News

SQZ

SQZ Biotechnologies (SQZ)

SQZ Biotechnologies Company
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:SQZ
DatumZeitQuelleÜberschriftSymbolFirma
06/05/202412h25GlobeNewswire Inc.Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd WiderNYSE:SQZSQZ Biotechnologies Company
23/01/202422h31Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNYSE:SQZSQZ Biotechnologies Company
22/12/202323h18Edgar (US Regulatory)Form 8-K - Current reportNYSE:SQZSQZ Biotechnologies Company
08/11/202322h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:SQZSQZ Biotechnologies Company
15/09/202315h04Edgar (US Regulatory)Form 8-K - Current reportNYSE:SQZSQZ Biotechnologies Company
25/07/202313h34Edgar (US Regulatory)Form 8-K - Current reportNYSE:SQZSQZ Biotechnologies Company
07/07/202322h30Edgar (US Regulatory)Form 8-K - Current reportNYSE:SQZSQZ Biotechnologies Company
03/07/202319h53Edgar (US Regulatory)Form 8-K - Current reportNYSE:SQZSQZ Biotechnologies Company
15/06/202322h47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:SQZSQZ Biotechnologies Company
15/06/202322h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:SQZSQZ Biotechnologies Company
15/06/202322h43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:SQZSQZ Biotechnologies Company
15/06/202322h41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:SQZSQZ Biotechnologies Company
15/06/202322h40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:SQZSQZ Biotechnologies Company
15/06/202322h38Edgar (US Regulatory)Current Report Filing (8-k)NYSE:SQZSQZ Biotechnologies Company
15/06/202322h30Business WireSQZ Biotechnologies to Consolidate Shares with 1-for-10 Reverse Stock SplitNYSE:SQZSQZ Biotechnologies Company
10/05/202322h45Business WireSQZ Biotechnologies Reports First Quarter 2023 Financial Results and Recent Portfolio UpdatesNYSE:SQZSQZ Biotechnologies Company
10/05/202322h35Edgar (US Regulatory)Quarterly Report (10-q)NYSE:SQZSQZ Biotechnologies Company
05/05/202322h32Edgar (US Regulatory)Annual Report to Security Holders (ars)NYSE:SQZSQZ Biotechnologies Company
26/04/202322h32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NYSE:SQZSQZ Biotechnologies Company
26/04/202322h31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:SQZSQZ Biotechnologies Company
10/04/202322h32Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NYSE:SQZSQZ Biotechnologies Company
10/04/202322h31Edgar (US Regulatory)Current Report Filing (8-k)NYSE:SQZSQZ Biotechnologies Company
22/03/202321h50Business WireSQZ Biotechnologies Announces Confirmed Complete Response in HPV16+ Solid Tumor Patient in the Lowest-Dose Cohort of the SQZ-AAC-HPV-101 Clinical TrialNYSE:SQZSQZ Biotechnologies Company
22/03/202321h45Business WireSQZ Biotechnologies Reports Full Year 2022 Financial Results and Recent Portfolio UpdatesNYSE:SQZSQZ Biotechnologies Company
14/02/202320h25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:SQZSQZ Biotechnologies Company
14/02/202313h56Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:SQZSQZ Biotechnologies Company
14/02/202312h27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:SQZSQZ Biotechnologies Company
26/01/202322h49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:SQZSQZ Biotechnologies Company
26/01/202322h47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:SQZSQZ Biotechnologies Company
26/01/202322h47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:SQZSQZ Biotechnologies Company
 Showing the most relevant articles for your search:NYSE:SQZ

Kürzlich von Ihnen besucht

CCOM
US30
US 30
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
MCD
McDonalds
USOTC
RHHBY
Roche (QX)
TG
432
Arbor Metals
TG
BAS
BASF
TG
RHM
Rheinmetall
DBI
MDAX
MDAX
NASDAQ
MSFT
Microsoft
NYSE
XOM
Exxon Mobil
NYSE
JPM
JP Morgan Chase
USOTC
DTEGY
Deutsche Telekom (QX)
TG
NOV
Novo Nordisk
COIN
BTCUSD
Bitcoin
AMEX
XLE
Energy Select Sector SPDR
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten